Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2019

1-Year Primary Outcome Data From RECOVERY

Show Description +

Charles Wykoff, MD, PhD, shares the 1-year primary outcome data from the RECOVERY trial, which examined aflibercept in patients with PDR, extensive nonperfusion, and no DME.

Posted: 7/11/2019

1-Year Primary Outcome Data From RECOVERY

Charles Wykoff, MD, PhD, shares the 1-year primary outcome data from the RECOVERY trial, which examined aflibercept in patients with PDR, extensive nonperfusion, and no DME.

Posted: 7/11/2019


Please log in to leave a comment.